Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The objective of this study is to investigate the safety and effectiveness of Concerta in the treatment of children (ages 5 to 17 years old) and adults (ages 18 to 55 years old) with Bipolar I, Bipolar II and Bipolar Spectrum Disorder and comorbid ADHD over 8 weeks. This study seeks to study the short-term effectiveness of a long acting formulation of methylphenidate (Concerta) in the treatment of children and adults with bipolar disorder and comorbid ADHD adequately stabilized on an acceptable and stable regimen of anti-mania agents.
Epistemonikos ID: 5f123dcc39eeae87c4bf5fbe2422772bc04a4a07
First added on: May 04, 2024